Latest Funding News

Pacific Current Group has announced an on-market buy-back of up to 2 million shares, representing nearly 7% of its capital, aiming to enhance earnings per share and capital efficiency.

Green Critical Minerals is set to issue over 107 million shortfall shares to underwriters following the expiry of its quoted options, marking a significant step in its capital management strategy.

Eclipse Metals announces plans for a NASDAQ dual listing to boost its rare earth elements strategy and tap into North American capital markets, while maintaining its ASX presence.

Titan Minerals has landed a US$10 million strategic investment from Lingbao Gold International, acquiring nearly 10% of the company and setting the stage to fast-track its Dynasty Gold Project in Ecuador.

Vital Metals has locked in firm commitments for an extra $5.6 million placement, building on its August raise, to accelerate development of its Tardiff rare earths deposit in Canada.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

Haranga Resources has raised $14 million through an oversubscribed placement led by Collins St Gold Fund, aiming to fast-track exploration and development at its Lincoln and Ibel South gold projects.

Emyria has secured a multi-year funding extension with Medibank to launch its Empax mental health programs in Brisbane, marking a key step in its national expansion. This insurer-backed initiative aims to improve access to treatment for complex conditions like treatment-resistant depression and PTSD.

Carnaby Resources has landed a A$12.5 million investment from the Queensland government-backed QIC Critical Minerals and Battery Technology Fund, accelerating development of its Greater Duchess copper-gold project. The funding will underpin key feasibility studies and position the company for a final investment decision by late 2026.

Resolute Mining has agreed to support the sale of its 31.45 million shares in Loncor Gold to Chengtun Mining Group for C$1.38 per share, a move that will strengthen its balance sheet and accelerate key African projects.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

Bank of Queensland’s August 2025 APRA Basel III Pillar 3 report reveals stable capital ratios and robust liquidity metrics, underscoring its disciplined risk management amid portfolio growth.